Breaking News
European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval
[ad_1]
European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval
BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.
[ad_2]
